Uterine leiomyomas are benign tumors affecting a large proportion of the female population.
Despite the very high prevalence, the molecular basis for understanding the onset and …

Uterine leiomyoma is a benign smooth muscle tumor characterized by a high incidence in
women of reproductive age. The aetiology of this tumor is still unknown but established risk …

Background: Recent advances in proteomics present enormous opportunities to discover
proteome related disparities and thus understanding the molecular mechanisms related to a …

In recent years, significant advancements have been made in the way the complex
proteome samples are compared but the ultimate goal of routine biomarker discovery has …

Uterine leiomyomas are benign smooth muscle cell tumors originating from the myometrium.
In this study we focus on leiomyoma and normal myometrium phosphoproteome, to identify …

Uterine smooth muscular neoplastic growths like benign leiomyomas (UL) and metastatic
leiomyosarcomas (ULMS) share similar clinical symptoms, radiological and histological …

Recent progresses in quantitative proteomics have offered opportunities to discover plasma
proteins as biomarkers for tracking the progression and for understanding the molecular …

This study utilized both cDNA microarray and two‐dimensional protein gel electrophoresis
technology to investigate the multiple interactions of genes and proteins involved in uterine …

Study question Can single-cell transcriptomics and proteomics contribute to a better
understanding uterine of leiomyoma tumorigenesis? Summary answer We demonstrate the …

Uterine leiomyoma is the most common benign smooth muscle cell tumor of the uterus.
Proteomics is a powerful tool for the analysis of complex mixtures of proteins. In our study …